Home > Cannabinoids and the endocannabinoid system in fibromyalgia: a review of preclinical and clinical research.

Bourke, Stephanie and Schlag, Anne Katrin and O'Sullivan, Saoirse Elizabeth and Nutt, David J and Finn, David P (2022) Cannabinoids and the endocannabinoid system in fibromyalgia: a review of preclinical and clinical research. Pharmacology & Therapeutics, 240, 108216. https://doi.org/10.1016/j.pharmthera.2022.108216.

External website: https://www.sciencedirect.com/science/article/pii/...

Characterised by chronic widespread musculoskeletal pain, generalised hyperalgesia, and psychological distress, fibromyalgia (FM) is a significant unmet clinical need. The endogenous cannabinoid system plays an important role in modulating both pain and the stress response. Here, we appraise the evidence, from preclinical and clinical studies, for a role of the endocannabinoid system in FM and the therapeutic potential of targeting the endocannabinoid system. While many animal models have been used to study FM, the reserpine-induced myalgia model has emerged as the most translatable to the clinical phenotype. Inhibition of fatty acid amide hydrolase (FAAH) has shown promise in preclinical studies, ameliorating pain- and anxiety-related behaviour, and not associated with the development of tolerance. Clinically, there is evidence for alterations in the endocannabinoid system in patients with FM, including single nucleotide polymorphisms and increased levels of circulating endocannabinoids and related N-acylethanolamines. Single entity cannabinoids, cannabis, and cannabis-based medicines in patients with FM show promise therapeutically but limitations in methodology and lack of longitudinal studies to assess efficacy and tolerability preclude the current recommendation for their use in patients with FM. Gaps in the literature that warrant further investigation are discussed, particularly the need for further development of animal models with high validity for the multifaceted nature of FM, balanced studies to eliminate sex-bias in preclinical research, and ultimately, better translation between preclinical and clinical research.

Item Type
Publication Type
Irish-related, Open Access, Review, Article
Drug Type
Intervention Type
Treatment method
21 May 2022
Identification #
Related (external) link

Click here to request a copy of this literature

Repository Staff Only: item control page